Advanced

Second-hand exposure to tobacco smoke and its effect on disease activity in Swedish rheumatoid arthritis patients. Data from BARFOT, a multicentre study of rheumatoid arthritis

Soderlin, M. K.; Andersson, M. and Bergman, Stefan LU (2013) In Clinical and Experimental Rheumatology 31(1). p.122-124
Abstract
Objective. We studied the prevalence and effect on disease activity of ever having had second-hand exposure to tobacco smoke in Swedish rheumatoid arthritis (RA) patients who had never smoked. Methods. Between 1992 and 2005, 2,800 patients were included in the BARFOT early-RA study in Sweden. Disease Activity Score 28 joints (DAS28), C-reactive protein (CRP), Health Assessment Questionnaire (HAQ), rheumatoid factor (RF), general health and pain visual analogue scales (VAS), and drug treatment were registered at inclusion and at follow-up at 3, 6, and 12 months and 2 and 5 years. EULAR response criteria were applied at the same follow-up points. In 2010, a self-completion postal questionnaire was sent to 2,102 patients in the BARFOT study... (More)
Objective. We studied the prevalence and effect on disease activity of ever having had second-hand exposure to tobacco smoke in Swedish rheumatoid arthritis (RA) patients who had never smoked. Methods. Between 1992 and 2005, 2,800 patients were included in the BARFOT early-RA study in Sweden. Disease Activity Score 28 joints (DAS28), C-reactive protein (CRP), Health Assessment Questionnaire (HAQ), rheumatoid factor (RF), general health and pain visual analogue scales (VAS), and drug treatment were registered at inclusion and at follow-up at 3, 6, and 12 months and 2 and 5 years. EULAR response criteria were applied at the same follow-up points. In 2010, a self-completion postal questionnaire was sent to 2,102 patients in the BARFOT study enquiring about lifestyle habits such as whether they had ever been exposed to tobacco smoke as a result of someone else smoking. Results. A total of 96311,421 patients (68%) had had second-hand exposure to tobacco smoke. At 3, 6, and 12 months, at 2 years, and at 5 years of follow-up, there were no differences in EULAR response between patients who had never smoked and who had been exposed or had not been exposed second-hand to tobacco smoke (p=0.91, p=0.88, p=0.84, p=0.61 and p=0.85, respectively). Conclusions. We did not find any association between second-hand exposure to tobacco smoke and disease activity in RA. (Less)
Please use this url to cite or link to this publication:
author
organization
publishing date
type
Contribution to journal
publication status
published
subject
keywords
rheumatoid arthritis, second-hand smoke, exposure, environmental tobacco, smoke, epidemiology
in
Clinical and Experimental Rheumatology
volume
31
issue
1
pages
122 - 124
publisher
Pacini
external identifiers
  • wos:000315758500018
  • scopus:84874891427
ISSN
1593-098X
language
English
LU publication?
yes
id
b1b743ef-05b4-4769-8ef9-78fc599032b0 (old id 3658120)
date added to LUP
2013-05-02 09:01:35
date last changed
2019-02-20 01:39:08
@article{b1b743ef-05b4-4769-8ef9-78fc599032b0,
  abstract     = {Objective. We studied the prevalence and effect on disease activity of ever having had second-hand exposure to tobacco smoke in Swedish rheumatoid arthritis (RA) patients who had never smoked. Methods. Between 1992 and 2005, 2,800 patients were included in the BARFOT early-RA study in Sweden. Disease Activity Score 28 joints (DAS28), C-reactive protein (CRP), Health Assessment Questionnaire (HAQ), rheumatoid factor (RF), general health and pain visual analogue scales (VAS), and drug treatment were registered at inclusion and at follow-up at 3, 6, and 12 months and 2 and 5 years. EULAR response criteria were applied at the same follow-up points. In 2010, a self-completion postal questionnaire was sent to 2,102 patients in the BARFOT study enquiring about lifestyle habits such as whether they had ever been exposed to tobacco smoke as a result of someone else smoking. Results. A total of 96311,421 patients (68%) had had second-hand exposure to tobacco smoke. At 3, 6, and 12 months, at 2 years, and at 5 years of follow-up, there were no differences in EULAR response between patients who had never smoked and who had been exposed or had not been exposed second-hand to tobacco smoke (p=0.91, p=0.88, p=0.84, p=0.61 and p=0.85, respectively). Conclusions. We did not find any association between second-hand exposure to tobacco smoke and disease activity in RA.},
  author       = {Soderlin, M. K. and Andersson, M. and Bergman, Stefan},
  issn         = {1593-098X},
  keyword      = {rheumatoid arthritis,second-hand smoke,exposure,environmental tobacco,smoke,epidemiology},
  language     = {eng},
  number       = {1},
  pages        = {122--124},
  publisher    = {Pacini},
  series       = {Clinical and Experimental Rheumatology},
  title        = {Second-hand exposure to tobacco smoke and its effect on disease activity in Swedish rheumatoid arthritis patients. Data from BARFOT, a multicentre study of rheumatoid arthritis},
  volume       = {31},
  year         = {2013},
}